BRIMCARE T

BRIMCARE T is a combination ophthalmic solution containing Brimonidine (an alpha-2 adrenergic agonist) and Timolol (a beta-adrenergic blocker), specially formulated to manage intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. This dual-action formula effectively reduces the production of aqueous humor and enhances its outflow, providing powerful and sustained pressure-lowering effects.

The synergistic effect of Brimonidine and Timolol in BRIMCARE T ensures better control of IOP compared to monotherapy, minimizing the risk of optic nerve damage and vision loss. It is well-tolerated with a convenient twice-daily dosage, making it an ideal long-term solution for glaucoma management. Regular use under medical supervision helps preserve vision and protects against disease progression.